Ihuman Inc Stock Revenue Per Share
| IH Stock | USD 1.72 0.04 2.27% |
Ihuman Inc fundamentals help investors to digest information that contributes to Ihuman's financial success or failures. It also enables traders to predict the movement of Ihuman Stock. The fundamental analysis module provides a way to measure Ihuman's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ihuman stock.
| Last Reported | Projected for Next Year | ||
| Revenue Per Share | 18.57 | 9.92 |
Ihuman | Revenue Per Share |
Ihuman Inc Company Revenue Per Share Analysis
Ihuman's Revenue per Share is a ratio of total revenue earned per one share of common stock over a single fiscal year. It is calculated by dividing sales revenue earned over 12 months by the average number of outstanding shares. Revenue used in the calculation of this ratio is typically recorded when cash or cash equivalents are exchanged for services or goods.
Current Ihuman Revenue Per Share | 9.92 |
Most of Ihuman's fundamental indicators, such as Revenue Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ihuman Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ihuman Revenue Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Ihuman is extremely important. It helps to project a fair market value of Ihuman Stock properly, considering its historical fundamentals such as Revenue Per Share. Since Ihuman's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ihuman's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ihuman's interrelated accounts and indicators.
Click cells to compare fundamentals
Ihuman Revenue Per Share Historical Pattern
Today, most investors in Ihuman Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ihuman's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Ihuman revenue per share as a starting point in their analysis.
Ihuman Revenue Per Share |
| Timeline |
Revenue per share does not take into account any of company expenses and is helpful only when comparing relative sale figures within a given industry.
| Competition |
Ihuman Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Ihuman Revenue Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ihuman's direct or indirect competition against its Revenue Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ihuman could also be used in its relative valuation, which is a method of valuing Ihuman by comparing valuation metrics of similar companies.Ihuman is currently under evaluation in revenue per share category among its peers.
Ihuman Current Valuation Drivers
We derive many important indicators used in calculating different scores of Ihuman from analyzing Ihuman's financial statements. These drivers represent accounts that assess Ihuman's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Ihuman's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 5.0B | 5.4B | 941.4M | 955.9M | 1.2B | 1.2B | |
| Enterprise Value | 4.9B | 4.5B | 120.3M | (85.0M) | 7.9M | 7.5M |
Ihuman Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0456 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | (69.95 M) | ||||
| Shares Outstanding | 23.42 M | ||||
| Shares Owned By Institutions | 0.61 % | ||||
| Number Of Shares Shorted | 3.66 K | ||||
| Price To Earning | 7.83 X | ||||
| Price To Book | 0.71 X | ||||
| Price To Sales | 0.09 X | ||||
| Revenue | 1.02 B | ||||
| Gross Profit | 660.62 M | ||||
| EBITDA | 171.58 M | ||||
| Net Income | 180.91 M | ||||
| Cash And Equivalents | 1.05 B | ||||
| Cash Per Share | 16.08 X | ||||
| Total Debt | 3.86 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 2.27 X | ||||
| Book Value Per Share | 18.16 X | ||||
| Cash Flow From Operations | 172.12 M | ||||
| Short Ratio | 0.15 X | ||||
| Earnings Per Share | 0.26 X | ||||
| Target Price | 3.86 | ||||
| Number Of Employees | 783 | ||||
| Beta | 0.47 | ||||
| Market Capitalization | 89.82 M | ||||
| Total Asset | 1.45 B | ||||
| Retained Earnings | (140.46 M) | ||||
| Working Capital | 891.68 M | ||||
| Annual Yield | 0.06 % | ||||
| Net Asset | 1.45 B |
About Ihuman Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ihuman Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ihuman using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ihuman Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Ihuman Piotroski F Score and Ihuman Altman Z Score analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Earnings Share 0.26 | Revenue Per Share 18.263 | Quarterly Revenue Growth (0.11) | Return On Assets 0.0456 |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.